(Q38139624)

29 August 2017

title

Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases (English)

1 reference

29 August 2017

2

Gregor P C Drummen

1 reference

ORCID Public Data File 2021

29 August 2017

1 reference

author name string

Tian-Biao Zhou

1

1 reference

29 August 2017

Zong-Pei Jiang

3

1 reference

29 August 2017

Yao-Bin Long

4

1 reference

29 August 2017

Yuan-Han Qin

5

1 reference

29 August 2017

publication date

19 September 2013

1 reference

Journal of Receptors and Signal Transduction

29 August 2017

published in

1 reference

29 August 2017

volume

33

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

349-352

1 reference

Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present).

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PTB-associated splicing factor (PSF) is a PPARγ-binding protein and growth regulator of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Signaling Crosstalk between PPARγ and BMP2 in Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

TGFβ1 Controls PPARγ Expression, Transcriptional Potential, and Activity, in Part, through Smad3 Signaling in Murine Lung Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The molecular physiology of nuclear retinoic acid receptors. From health to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Association of retinoic acid receptors with extracellular matrix accumulation in rats with renal interstitial fibrosis disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid receptors beta and gamma do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid synthesis and signaling during early organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid synthesis and functions in early embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid signaling and the evolution of chordates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Between death and survival: retinoic acid in regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The controversial role of retinoic acid in fibrotic diseases: analysis of involved signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Role of the retinoic acid receptor-α in HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Novel retinoic acid receptor alpha agonists for treatment of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Signaling pathways of apoE and its role of gene expression in glomerulus diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The signaling pathways of LMX1B and its role in glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

The potential mechanism for the different expressions of gelatinases induced by all-trans retinoic acid in different cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Signaling pathways of prohibitin and its role in diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Effects of PPARγ Ligands on Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

Expression of NPM-RARalpha fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.838786

10.3109/10799893.2013.838786

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference